eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Review: could Remicade cause Hepatosplenic t-cell lymphoma?

Summary: Hepatosplenic t-cell lymphoma is found among people who take Remicade, especially for people who are male, 10-19 old, have been taking the drug for 2 - 5 years, also take medication Mercaptopurine, and have Crohn's disease.

We study 85,102 people who have side effects while taking Remicade from FDA and social media. Among them, 282 have Hepatosplenic t-cell lymphoma. Find out below who they are, when they have Hepatosplenic t-cell lymphoma and more.

You are not alone: join a support group for people who take Remicade and have Hepatosplenic t-cell lymphoma >>>

 

Remicade

Remicade has active ingredients of infliximab. It is often used in crohn's disease. (latest outcomes from 85,507 Remicade users)

Hepatosplenic t-cell lymphoma

Hepatosplenic t-cell lymphoma (neoplasm comprising medium-sized cytotoxic t-cells that show a significant sinusoidal infiltration in the liver, spleen, and bone marrow) has been reported by people with crohn's disease, ulcerative colitis, inflammatory bowel disease, colitis, irritable bowel syndrome. (latest reports from 376 Hepatosplenic t-cell lymphoma patients)

On Mar, 31, 2015: 85,097 people reported to have side effects when taking Remicade. Among them, 282 people (0.33%) have Hepatosplenic T-cell Lymphoma.

Trend of Hepatosplenic t-cell lymphoma in Remicade reports

Time on Remicade when people have Hepatosplenic t-cell lymphoma * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years
Hepatosplenic t-cell lymphoma39.00%18.00%3.00%1.00%39.00%0.00%0.00%

Gender of people who have Hepatosplenic t-cell lymphoma when taking Remicade * :

FemaleMale
Hepatosplenic t-cell lymphoma4.34%95.66%

Age of people who have Hepatosplenic t-cell lymphoma when taking Remicade * :

0-12-910-1920-2930-3940-4950-5960+
Hepatosplenic t-cell lymphoma0.00%0.00%53.02%15.87%22.86%0.00%7.14%1.11%

Severity of Hepatosplenic t-cell lymphoma when taking Remicade ** :

n/a

How people recovered from Hepatosplenic t-cell lymphoma ** :

n/a

Top conditions involved for these people * :

  1. Crohn's disease (282 people, 100.00%)
  2. Colitis ulcerative (64 people, 22.70%)
  3. Inflammatory bowel disease (33 people, 11.70%)
  4. Irritable bowel syndrome (24 people, 8.51%)
  5. Ill-defined disorder (15 people, 5.32%)

Top co-used drugs for these people * :

  1. Mercaptopurine (282 people, 100.00%)
  2. Imuran (282 people, 100.00%)
  3. Azathioprine (238 people, 84.40%)
  4. Asacol (182 people, 64.54%)
  5. Prednisone (180 people, 63.83%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of remicade and hepatosplenic t-cell lymphoma on

Do you have Hepatosplenic T-cell Lymphoma while taking Remicade?

 

 

 

You are not alone! Join a support group on :
- support group for people who take Remicade and have Hepatosplenic T-cell Lymphoma
- support group for people who take Remicade
- support group for people who have Hepatosplenic T-cell Lymphoma

Drugs in real world that are associated with:

Could your condition cause:

Recent related drug studies (Check your drugs):

Recent Remicade related drug comparison:

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.